MGMT promoter methylation has been detected in plasma ctDNA of glioma patients, and methylation status correlated with GBM tissue, suggesting that liquid biopsy material could have potential in detecting MGMT promoter methylation status [13]. The gene discussed is MGMT; the disease is central nervous system cancer.